Respire Diagnostics Analysis: $59K Raised
What is Respire Diagnostics?
Respire Diagnostics develops electrochemical sensors that analyze exhaled breath to detect biomarkers like hydrogen peroxide, lactate, and nitrites. The company manufactures its own EBC condenser and sensors in-house to ensure quality and cost efficiency. Products are targeted at early-stage clinical validation and regulatory approval for respiratory disease monitoring.
Location
London, United Kingdom
Employees
1-10
Founded
2020
Funding Status
Not Funded
Product Features & Capabilities
- REDI EBC Condenser
- REDI Sensors
- REDI Accessories
Use Cases
Detect COPD and asthma biomarkers in exhaled breath; Monitor sepsis through hydrogen peroxide and lactate levels; Identify respiratory conditions using nitrites as a proxy; Validate biomarker presence in clinical trials with Royal Brompton and Harefield Hospital; Support early-stage disease screening in healthcare settings
Other Considerations
Spin-out from Imperial College London; Funded by UK Research and Innovation's Innovate UK, Medtech SuperConnector and EIT Health; Completed Tech Transfer at Imperial College London (TRL4); Conducted clinical studies at Royal Brompton and Harefield Hospital (TRL5); Working towards ISO13485 regulatory approval
See something that needs updating? Suggest edits to this profile.